{
    "@context": "https://api.researchmap.jp/researcher.jsonld",
    "@id": "https://api.researchmap.jp/read0022646?format=json",
    "@type": "researchers",
    "rm:user_id": "1000062092",
    "rm:creator_id": "1000062092",
    "rm:creator_type": "myself",
    "rm:created": "2005-12-07T15:00:00Z",
    "rm:modifier_id": "1000062092",
    "rm:modifier_type": "myself",
    "rm:modified": "2021-10-26T04:48:10Z",
    "permalink": "read0022646",
    "family_name": {
        "ja": "櫻田",
        "ja-Kana": "サクラダ",
        "en": "Sakurada"
    },
    "given_name": {
        "ja": "忍",
        "ja-Kana": "シノブ",
        "en": "Shinobu"
    },
    "display_name_kana": "disclosed",
    "display_nickname": "disclosed",
    "display_image": "disclosed",
    "display_contact_point": "disclosed",
    "affiliations": [
        {
            "affiliation": {
                "ja": "東北薬科大学",
                "en": "Tohoku Pharmaceutical University"
            },
            "section": {
                "ja": "薬学部 薬学科 機能形態学教室",
                "en": "Faculty of Pharmaceutical Sciences, Department of Pharmaceutical Science, Department of Physiology and Anatomy"
            },
            "job": {
                "ja": "教授",
                "en": "Professor"
            },
            "display_affiliation": "disclosed",
            "display_job": "disclosed",
            "rm:institution_code": "9999999999"
        }
    ],
    "degrees": [
        {
            "degree": {
                "ja": "薬学博士",
                "en": "Pharmaceutical Doctor"
            },
            "degree_institution": {
                "ja": "東北薬科大学",
                "en": "Tohoku Pharmaceutical University"
            },
            "display_degree": "disclosed",
            "rm:institution_code": "9999999999"
        }
    ],
    "display_profile": "disclosed",
    "display_url": "disclosed",
    "identifiers": {
        "j_global_id": [
            "200901070661383301"
        ]
    },
    "rm:erad_id_verified": false,
    "rm:orc_id_verified": false,
    "display_erad_id": "closed",
    "display_orc_id": "closed",
    "display_researcher_id": "disclosed",
    "display_j_global_id": "disclosed",
    "see_also": [
        {
            "label": "j_global",
            "@id": "https://jglobal.jst.go.jp/detail?JGLOBAL_ID=200901070661383301"
        }
    ],
    "@graph": [
        {
            "@id": "https://api.researchmap.jp/read0022646/research_interests",
            "@type": "research_interests",
            "@reverse": "https://api.researchmap.jp/read0022646",
            "total_items": 2,
            "items": [
                {
                    "@id": "https://api.researchmap.jp/read0022646/research_interests/1751788",
                    "@type": "research_interests",
                    "@reverse": "https://api.researchmap.jp/read0022646/research_interests",
                    "rm:id": "1751788",
                    "rm:user_id": "1000062092",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000062092",
                    "rm:creator_type": "myself",
                    "rm:created": "2005-12-07T15:00:00Z",
                    "rm:modifier_id": "1000062092",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2005-12-07T15:00:00Z",
                    "keyword": {
                        "ja": "薬理学"
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/read0022646/research_interests/1751787",
                    "@type": "research_interests",
                    "@reverse": "https://api.researchmap.jp/read0022646/research_interests",
                    "rm:id": "1751787",
                    "rm:user_id": "1000062092",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000062092",
                    "rm:creator_type": "myself",
                    "rm:created": "2005-12-07T15:00:00Z",
                    "rm:modifier_id": "1000062092",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2005-12-07T15:00:00Z",
                    "keyword": {
                        "en": "pharmacology"
                    }
                }
            ]
        },
        {
            "@id": "https://api.researchmap.jp/read0022646/research_areas",
            "@type": "research_areas",
            "@reverse": "https://api.researchmap.jp/read0022646",
            "total_items": 1,
            "items": [
                {
                    "@id": "https://api.researchmap.jp/read0022646/research_areas/1296731",
                    "@type": "research_areas",
                    "@reverse": "https://api.researchmap.jp/read0022646/research_areas",
                    "rm:id": "1296731",
                    "rm:user_id": "1000062092",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000062092",
                    "rm:creator_type": "myself",
                    "rm:created": "2005-12-07T15:00:00Z",
                    "rm:modifier_id": "1000062092",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2005-12-07T15:00:00Z",
                    "discipline_number": "A189",
                    "item_number": "A47040",
                    "discipline": {
                        "ja": "ライフサイエンス",
                        "en": "Life sciences"
                    },
                    "research_field": {
                        "ja": "薬理学",
                        "en": "Pharmacology"
                    }
                }
            ]
        },
        {
            "@id": "https://api.researchmap.jp/read0022646/committee_memberships",
            "@type": "committee_memberships",
            "@reverse": "https://api.researchmap.jp/read0022646",
            "total_items": 3,
            "items": [
                {
                    "@id": "https://api.researchmap.jp/read0022646/committee_memberships/812906",
                    "@type": "committee_memberships",
                    "@reverse": "https://api.researchmap.jp/read0022646/committee_memberships",
                    "rm:id": "812906",
                    "rm:user_id": "1000062092",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000062092",
                    "rm:creator_type": "myself",
                    "rm:created": "2005-12-07T15:00:00Z",
                    "rm:modifier_id": "1000062092",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2005-12-07T15:00:00Z",
                    "from_date": "1999",
                    "committee_name": {
                        "ja": "評議員"
                    },
                    "association": {
                        "ja": "日本神経精神薬理学会"
                    },
                    "description": {
                        "ja": "日本神経精神薬理学会"
                    },
                    "committee_type": "society"
                },
                {
                    "@id": "https://api.researchmap.jp/read0022646/committee_memberships/812907",
                    "@type": "committee_memberships",
                    "@reverse": "https://api.researchmap.jp/read0022646/committee_memberships",
                    "rm:id": "812907",
                    "rm:user_id": "1000062092",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000062092",
                    "rm:creator_type": "myself",
                    "rm:created": "2005-12-07T15:00:00Z",
                    "rm:modifier_id": "1000062092",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2005-12-07T15:00:00Z",
                    "from_date": "1997",
                    "committee_name": {
                        "ja": "世話人"
                    },
                    "association": {
                        "ja": "鎮痛薬オピオイドペプチドシンポジウム"
                    },
                    "description": {
                        "ja": "鎮痛薬オピオイドペプチドシンポジウム"
                    },
                    "committee_type": "society"
                },
                {
                    "@id": "https://api.researchmap.jp/read0022646/committee_memberships/812905",
                    "@type": "committee_memberships",
                    "@reverse": "https://api.researchmap.jp/read0022646/committee_memberships",
                    "rm:id": "812905",
                    "rm:user_id": "1000062092",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000062092",
                    "rm:creator_type": "myself",
                    "rm:created": "2005-12-07T15:00:00Z",
                    "rm:modifier_id": "1000062092",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2005-12-07T15:00:00Z",
                    "committee_name": {
                        "ja": "学術評議会"
                    },
                    "association": {
                        "ja": "日本薬理学会"
                    },
                    "description": {
                        "ja": "日本薬理学会"
                    },
                    "committee_type": "society"
                }
            ]
        },
        {
            "@id": "https://api.researchmap.jp/read0022646/awards",
            "@type": "awards",
            "@reverse": "https://api.researchmap.jp/read0022646",
            "total_items": 1,
            "items": [
                {
                    "@id": "https://api.researchmap.jp/read0022646/awards/428487",
                    "@type": "awards",
                    "@reverse": "https://api.researchmap.jp/read0022646/awards",
                    "rm:id": "428487",
                    "rm:user_id": "1000062092",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000062092",
                    "rm:creator_type": "myself",
                    "rm:created": "2005-12-07T15:00:00Z",
                    "rm:modifier_id": "1000062092",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2005-12-07T15:00:00Z",
                    "award_name": {
                        "ja": "薬学会東北支部奨励賞"
                    },
                    "award_date": "1981",
                    "address_country": "JPN"
                }
            ]
        },
        {
            "@id": "https://api.researchmap.jp/read0022646/misc",
            "@type": "misc",
            "@reverse": "https://api.researchmap.jp/read0022646",
            "total_items": 306,
            "items": [
                {
                    "@id": "https://api.researchmap.jp/read0022646/misc/15871759",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0022646/misc",
                    "rm:id": "15871759",
                    "rm:user_id": "1000062092",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000062092",
                    "rm:creator_type": "myself",
                    "rm:created": "2005-12-07T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-05-08T14:34:41Z",
                    "paper_title": {
                        "en": "Effects of intraplantar injections of nociceptin and its N-terminal fragments on nociceptive and desensitized responses induced by capsaicin in mice"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "T Sakurada"
                            },
                            {
                                "name": "T Komatsu"
                            },
                            {
                                "name": "T Moriyama"
                            },
                            {
                                "name": "M Sasaki"
                            },
                            {
                                "name": "K Sanai"
                            },
                            {
                                "name": "T Orito"
                            },
                            {
                                "name": "C Sakurada"
                            },
                            {
                                "name": "S Sakurada"
                            }
                        ]
                    },
                    "description": {
                        "en": "Injection of capsaicin into the hindpaw has been employed as a model of chemogenic nociception in in ice. Intraplantar injection of nociceptin (30-240 pmol) produced a significant and dose-dependent anti nociceptive activity in the capsaicin test. The nociceptin N-terminal fragments, (1-11) and (1-13), were also active with a potency higher than nociceptin and comparable to nociceptin, respectively. Intraplantar injection of the nociceptin (1-7) fragment had no effect on capsaicin-induced nociception. Antinociception induced by nociceptin or nociceptin (1-13) was reversed significantly by intraplantar co-injection of [Nphe(1)]nociceptin (1-13)NH2, an orphan opioid receptor-like I (ORL1) receptor antagonist, whereas local injection of the antagonist did not interfere with the action of nociceptin (1-11). Nociceptin (1-11) was approximately 2.0-fold more potent than naturally Occurring peptide nociceptin, and 10-fold more active than intraplantar morphine. Nociceptive licking/biting response to intraplantar injection of capsaicin was desensitized by repeated injections of capsaicin at the interval of 15 min. Desensitization induced by capsaicin was attenuated significantly by co-injection of nociceptin at much lower doses than antinociceptive ED50 for nociceptin. Capsaicin desensitization was also decreased by co-injection of nociceptin (1-11) and (1-13) to a similar extent. The present results indicate that not only nociceptin but also the N-terminal fragment (1-13) possesses a local peripheral antinociceptive action, which may be mediated by peripheral ORL1 receptors. In addition, the difference of the effective doses suggests that the antinociceptive action and inhibition of capsaicin-induced desenitization by nociceptin, nociceptin (1-11) and (1-13), may involve distinct mechanisms at the level of the peripheral nerve terminal. (c) 2005 Elsevier Inc. All rights reserved."
                    },
                    "publisher": {
                        "en": "ELSEVIER SCIENCE INC"
                    },
                    "publication_date": "2005-12",
                    "publication_name": {
                        "en": "PEPTIDES"
                    },
                    "volume": "26",
                    "number": "12",
                    "starting_page": "2505",
                    "ending_page": "2512",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1016/j.peptides.2005.05.022"
                        ],
                        "issn": [
                            "0196-9781"
                        ],
                        "wos_id": [
                            "WOS:000233976400021"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/j.peptides.2005.05.022",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000233976400021&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0022646/misc/15871529",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0022646/misc",
                    "rm:id": "15871529",
                    "rm:user_id": "1000062092",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000062092",
                    "rm:creator_type": "myself",
                    "rm:created": "2005-12-07T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-05-08T14:34:41Z",
                    "paper_title": {
                        "en": "Effects of intraplantar injections of nociceptin and its N-terminal fragments on nociceptive and desensitized responses induced by capsaicin in mice"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "T Sakurada"
                            },
                            {
                                "name": "T Komatsu"
                            },
                            {
                                "name": "T Moriyama"
                            },
                            {
                                "name": "M Sasaki"
                            },
                            {
                                "name": "K Sanai"
                            },
                            {
                                "name": "T Orito"
                            },
                            {
                                "name": "C Sakurada"
                            },
                            {
                                "name": "S Sakurada"
                            }
                        ]
                    },
                    "description": {
                        "en": "Injection of capsaicin into the hindpaw has been employed as a model of chemogenic nociception in in ice. Intraplantar injection of nociceptin (30-240 pmol) produced a significant and dose-dependent anti nociceptive activity in the capsaicin test. The nociceptin N-terminal fragments, (1-11) and (1-13), were also active with a potency higher than nociceptin and comparable to nociceptin, respectively. Intraplantar injection of the nociceptin (1-7) fragment had no effect on capsaicin-induced nociception. Antinociception induced by nociceptin or nociceptin (1-13) was reversed significantly by intraplantar co-injection of [Nphe(1)]nociceptin (1-13)NH2, an orphan opioid receptor-like I (ORL1) receptor antagonist, whereas local injection of the antagonist did not interfere with the action of nociceptin (1-11). Nociceptin (1-11) was approximately 2.0-fold more potent than naturally Occurring peptide nociceptin, and 10-fold more active than intraplantar morphine. Nociceptive licking/biting response to intraplantar injection of capsaicin was desensitized by repeated injections of capsaicin at the interval of 15 min. Desensitization induced by capsaicin was attenuated significantly by co-injection of nociceptin at much lower doses than antinociceptive ED50 for nociceptin. Capsaicin desensitization was also decreased by co-injection of nociceptin (1-11) and (1-13) to a similar extent. The present results indicate that not only nociceptin but also the N-terminal fragment (1-13) possesses a local peripheral antinociceptive action, which may be mediated by peripheral ORL1 receptors. In addition, the difference of the effective doses suggests that the antinociceptive action and inhibition of capsaicin-induced desenitization by nociceptin, nociceptin (1-11) and (1-13), may involve distinct mechanisms at the level of the peripheral nerve terminal. (c) 2005 Elsevier Inc. All rights reserved."
                    },
                    "publisher": {
                        "en": "ELSEVIER SCIENCE INC"
                    },
                    "publication_date": "2005-12",
                    "publication_name": {
                        "en": "PEPTIDES"
                    },
                    "volume": "26",
                    "number": "12",
                    "starting_page": "2505",
                    "ending_page": "2512",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1016/j.peptides.2005.05.022"
                        ],
                        "issn": [
                            "0196-9781"
                        ],
                        "wos_id": [
                            "WOS:000233976400021"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/j.peptides.2005.05.022",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000233976400021&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0022646/misc/15871757",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0022646/misc",
                    "rm:id": "15871757",
                    "rm:user_id": "1000062092",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000062092",
                    "rm:creator_type": "myself",
                    "rm:created": "2005-12-07T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-05-07T14:25:59Z",
                    "paper_title": {
                        "en": "Enhanced antinociception by intracerebroventricularly administered orexin A in histamine H1 or H2 receptor gene knockout mice"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "JI Mobarakeh"
                            },
                            {
                                "name": "K Takahashi"
                            },
                            {
                                "name": "S Sakurada"
                            },
                            {
                                "name": "S Nishino"
                            },
                            {
                                "name": "H Watanabe"
                            },
                            {
                                "name": "M Kato"
                            },
                            {
                                "name": "N Naghdi"
                            },
                            {
                                "name": "K Yanai"
                            }
                        ]
                    },
                    "description": {
                        "en": "Orexins are neuropeptides that are mostly expressed in the posterior and lateral hypothalamus, and related to the central control of appetite, arousal, and antinociception. Orexin neurons projected to the tuberomammillary nucleus and orexins may release histamine from the histamine neurons in this nucleus. Histamine is known to cause hypernociception. The roles of histamine HI and H2 receptors in the orexin A-induced anti nociception, however, have not been clarified yet. Here we studied the effects of histamine HI and H2 receptors on orexin Aproduced antinociception using histamine receptor knockout mice in four assays of nociception; the hot-plate, the tail-flick, the tail-pressure and the capsaicin tests. Furthermore we studied effects of histamine H I and H2 receptor antagonists on orexin A-produced antinociception in C57BL/6 mice. The antinociceptive effects of i.c.v. orexin A were greater in histamine H I receptor or H2 receptor knockout mice than in the wild-type mice in all four assays of pain. Furthermore, treatment of C57BL/6 mice with a combination of i.c.v. orexin A and D-chlorpheniramine (a histamine H I receptor antagonist) or cimetidine (a histamine H2 receptor antagonist) showed a greater antinociception than i.c.v. orexin A alone in all four assays. These findings suggest the possibility that orexin A may activate HI and H2 receptors in the supraspinal levels through the release of histamine from neurons, which might attenuate the antinociceptive effects of orexin A. Thus, the blocking of the histamine HI or H2 receptor may produce antinociception and enhance the orexin A-induced antinociception. (c) 2005 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved."
                    },
                    "publisher": {
                        "en": "ELSEVIER SCIENCE BV"
                    },
                    "publication_date": "2005-11",
                    "publication_name": {
                        "en": "PAIN"
                    },
                    "volume": "118",
                    "number": "1-2",
                    "starting_page": "254",
                    "ending_page": "262",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1016/j.pain.2005.08.024"
                        ],
                        "issn": [
                            "0304-3959"
                        ],
                        "wos_id": [
                            "WOS:000233281800032"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/j.pain.2005.08.024",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000233281800032&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0022646/misc/15871527",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0022646/misc",
                    "rm:id": "15871527",
                    "rm:user_id": "1000062092",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000062092",
                    "rm:creator_type": "myself",
                    "rm:created": "2005-12-07T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-05-07T14:25:59Z",
                    "paper_title": {
                        "en": "Enhanced antinociception by intracerebroventricularly administered orexin A in histamine H1 or H2 receptor gene knockout mice"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "JI Mobarakeh"
                            },
                            {
                                "name": "K Takahashi"
                            },
                            {
                                "name": "S Sakurada"
                            },
                            {
                                "name": "S Nishino"
                            },
                            {
                                "name": "H Watanabe"
                            },
                            {
                                "name": "M Kato"
                            },
                            {
                                "name": "N Naghdi"
                            },
                            {
                                "name": "K Yanai"
                            }
                        ]
                    },
                    "description": {
                        "en": "Orexins are neuropeptides that are mostly expressed in the posterior and lateral hypothalamus, and related to the central control of appetite, arousal, and antinociception. Orexin neurons projected to the tuberomammillary nucleus and orexins may release histamine from the histamine neurons in this nucleus. Histamine is known to cause hypernociception. The roles of histamine HI and H2 receptors in the orexin A-induced anti nociception, however, have not been clarified yet. Here we studied the effects of histamine HI and H2 receptors on orexin Aproduced antinociception using histamine receptor knockout mice in four assays of nociception; the hot-plate, the tail-flick, the tail-pressure and the capsaicin tests. Furthermore we studied effects of histamine H I and H2 receptor antagonists on orexin A-produced antinociception in C57BL/6 mice. The antinociceptive effects of i.c.v. orexin A were greater in histamine H I receptor or H2 receptor knockout mice than in the wild-type mice in all four assays of pain. Furthermore, treatment of C57BL/6 mice with a combination of i.c.v. orexin A and D-chlorpheniramine (a histamine H I receptor antagonist) or cimetidine (a histamine H2 receptor antagonist) showed a greater antinociception than i.c.v. orexin A alone in all four assays. These findings suggest the possibility that orexin A may activate HI and H2 receptors in the supraspinal levels through the release of histamine from neurons, which might attenuate the antinociceptive effects of orexin A. Thus, the blocking of the histamine HI or H2 receptor may produce antinociception and enhance the orexin A-induced antinociception. (c) 2005 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved."
                    },
                    "publisher": {
                        "en": "ELSEVIER SCIENCE BV"
                    },
                    "publication_date": "2005-11",
                    "publication_name": {
                        "en": "PAIN"
                    },
                    "volume": "118",
                    "number": "1-2",
                    "starting_page": "254",
                    "ending_page": "262",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1016/j.pain.2005.08.024"
                        ],
                        "issn": [
                            "0304-3959"
                        ],
                        "wos_id": [
                            "WOS:000233281800032"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/j.pain.2005.08.024",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000233281800032&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0022646/misc/15871525",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0022646/misc",
                    "rm:id": "15871525",
                    "rm:user_id": "1000062092",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000062092",
                    "rm:creator_type": "myself",
                    "rm:created": "2005-12-07T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-08-29T10:28:55Z",
                    "paper_title": {
                        "en": "Intrathecally-administered histamine facilitates nociception through tachykinin NK1 and histamine H1 receptors: A study in histidine decarboxylase gene knockout mice"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "Akiko Yoshida"
                            },
                            {
                                "name": "Jalal Izadi Mobarakeh"
                            },
                            {
                                "name": "Eiko Sakurai"
                            },
                            {
                                "name": "Shinobu Sakurada"
                            },
                            {
                                "name": "Tohru Orito"
                            },
                            {
                                "name": "Atsuo Kuramasu"
                            },
                            {
                                "name": "Masato Kato"
                            },
                            {
                                "name": "Kazuhiko Yanai"
                            }
                        ]
                    },
                    "description": {
                        "en": "Intrathecal injection of histamine elicited behavioral responses consisting of scratching, biting and licking in conscious mice. To study the participation of histamine in pain perception, histidine decarboxylase knockout mice were examined for pain threshold by means of three different kinds of noxious stimuli: thermal nociception (hot-plate, tail-flick, and paw-withdrawal), mechanical nociception (tail-pressure), and chemical nociception (formalin test and capsaicin test). Mutant mice lacking histidine decarboxylase showed significantly fewer nociceptive responses to the hot-plate, tail-flick, paw-withdrawal, tail-pressure, formalin and capsaicin tests. Sensitivity to noxious stimuli in the histidine decarboxylase knockout mice was significantly lower when compared to the wild-type mice. The intrathecally-administered histamine (400 pmol) significantly shortened the latency in the histidine decarboxylase knockout mice, but not in the wild-type mice in tail-flick tests. Pyrilamine, a histamine H1 receptor antagonist, but not ranitidine, a histamine H2 receptor antagonist, produced inhibition of the induced behavioral responses in the tail-flick test when co-administered with histamine. Sendide, a tachykinin NK1 receptor antagonist, inhibited histamine-induced nociceptive behavior in the histidine decarboxylase knockout mice. In contrast, the treatment with d-(-)-2 amino-5-phosponovaleric acid (d-APV), an N-methyl-d-aspartate (NMDA) receptor antagonist, did not prevent the induction of the behavioral responses by histamine. These studies substantiate the evidence that nociceptive behavior induced by intrathecal injection of histamine is largely mediated through tachykinin NK1 and histamine H1 receptors in the spinal cord. © 2005 Elsevier B.V. All rights reserved."
                    },
                    "publication_date": "2005-10-17",
                    "publication_name": {
                        "en": "European Journal of Pharmacology"
                    },
                    "volume": "522",
                    "number": "1-3",
                    "starting_page": "55",
                    "ending_page": "62",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1016/j.ejphar.2005.08.037"
                        ],
                        "issn": [
                            "0014-2999"
                        ],
                        "pm_id": [
                            "16212954"
                        ],
                        "scopus_id": [
                            "26844531973"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/j.ejphar.2005.08.037",
                            "is_downloadable": false
                        },
                        {
                            "label": "pubmed",
                            "@id": "https://www.ncbi.nlm.nih.gov/pubmed/16212954",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0022646/misc/15871756",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0022646/misc",
                    "rm:id": "15871756",
                    "rm:user_id": "1000062092",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000062092",
                    "rm:creator_type": "myself",
                    "rm:created": "2005-12-07T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-05-08T19:02:25Z",
                    "paper_title": {
                        "en": "Mechanisms of nociception evoked by intrathecal high-dose morphine"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "T Sakurada"
                            },
                            {
                                "name": "T Komatsu"
                            },
                            {
                                "name": "S Sakurada"
                            }
                        ]
                    },
                    "description": {
                        "en": "Morphine is recommended by WHO as the analgesic of choice for effective treatment of moderate to severe cancer pain [World Health Organisation. Cancer pain relief 2nd ed. Geneva: WHO: 1996]. Indeed spinally administered morphine at small doses injected intrathecally (i.t.) or intracerebroventricularly into animals produces a profound antinociception at both spinal and supraspinal sites. Conversely, high doses of spinally administered morphine elicit a series of scratching, biting and licking in mice, and vocalization and agitation in rats, indicative of a spontaneous nociceptive behavioural response. Hyperalgesia and allodynia are also induced by such morphine treatment in humans as well as animals. These behaviours are not an opioid receptor-mediated event. This article will review the potential mechanisms of spinally mediated nociceptive behaviour evoked by i.t. morphine at high concentrations. We will discuss a possible presynaptic release of nociceptive neurotransmitters/neuromodulators (e.g., substance P, glutamate and dynorphin) in the primary afferent fibers,following i.t. high-dose morphine. There must be all intimate interaction of i.t. high-dose morphine with tachykinin neurokinin I (NK1) receptors and multiple sites on the N-methyl-D-aspartate (NMDA) receptor complex in the dorsal spinal cord. Since the effect of NMDA receptor activation and the associated Ca2+ influx results ill production of nitric oxide (NO) by activation of NO synthase, it seems that spinal NO also plays an important role in nociception evoked by i.t. high-dose morphine. Morphine-3-glucuronide, one of the major metabolites of morphine, has been found to evoke nociceptive behaviour similar to that of i.t. high-dose morphine. It is plausible that morphine-3-glucuronide may be responsible for nociception seen after i.t. high-dose morphine treatment. The demonstration of neural mechanism underlying morphine-induced nociception provides a pharmacological basis for improved pain management with morphine at high doses. (c) 2005 Elsevier Inc. All rights reserved."
                    },
                    "publisher": {
                        "en": "ELSEVIER SCIENCE BV"
                    },
                    "publication_date": "2005-10",
                    "publication_name": {
                        "en": "NEUROTOXICOLOGY"
                    },
                    "volume": "26",
                    "number": "5",
                    "starting_page": "801",
                    "ending_page": "809",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1016/j.neuro.2004.12.011"
                        ],
                        "issn": [
                            "0161-813X"
                        ],
                        "wos_id": [
                            "WOS:000232916600009"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/j.neuro.2004.12.011",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000232916600009&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0022646/misc/15871526",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0022646/misc",
                    "rm:id": "15871526",
                    "rm:user_id": "1000062092",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000062092",
                    "rm:creator_type": "myself",
                    "rm:created": "2005-12-07T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-05-08T19:02:25Z",
                    "paper_title": {
                        "en": "Mechanisms of nociception evoked by intrathecal high-dose morphine"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "T Sakurada"
                            },
                            {
                                "name": "T Komatsu"
                            },
                            {
                                "name": "S Sakurada"
                            }
                        ]
                    },
                    "description": {
                        "en": "Morphine is recommended by WHO as the analgesic of choice for effective treatment of moderate to severe cancer pain [World Health Organisation. Cancer pain relief 2nd ed. Geneva: WHO: 1996]. Indeed spinally administered morphine at small doses injected intrathecally (i.t.) or intracerebroventricularly into animals produces a profound antinociception at both spinal and supraspinal sites. Conversely, high doses of spinally administered morphine elicit a series of scratching, biting and licking in mice, and vocalization and agitation in rats, indicative of a spontaneous nociceptive behavioural response. Hyperalgesia and allodynia are also induced by such morphine treatment in humans as well as animals. These behaviours are not an opioid receptor-mediated event. This article will review the potential mechanisms of spinally mediated nociceptive behaviour evoked by i.t. morphine at high concentrations. We will discuss a possible presynaptic release of nociceptive neurotransmitters/neuromodulators (e.g., substance P, glutamate and dynorphin) in the primary afferent fibers,following i.t. high-dose morphine. There must be all intimate interaction of i.t. high-dose morphine with tachykinin neurokinin I (NK1) receptors and multiple sites on the N-methyl-D-aspartate (NMDA) receptor complex in the dorsal spinal cord. Since the effect of NMDA receptor activation and the associated Ca2+ influx results ill production of nitric oxide (NO) by activation of NO synthase, it seems that spinal NO also plays an important role in nociception evoked by i.t. high-dose morphine. Morphine-3-glucuronide, one of the major metabolites of morphine, has been found to evoke nociceptive behaviour similar to that of i.t. high-dose morphine. It is plausible that morphine-3-glucuronide may be responsible for nociception seen after i.t. high-dose morphine treatment. The demonstration of neural mechanism underlying morphine-induced nociception provides a pharmacological basis for improved pain management with morphine at high doses. (c) 2005 Elsevier Inc. All rights reserved."
                    },
                    "publisher": {
                        "en": "ELSEVIER SCIENCE BV"
                    },
                    "publication_date": "2005-10",
                    "publication_name": {
                        "en": "NEUROTOXICOLOGY"
                    },
                    "volume": "26",
                    "number": "5",
                    "starting_page": "801",
                    "ending_page": "809",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1016/j.neuro.2004.12.011"
                        ],
                        "issn": [
                            "0161-813X"
                        ],
                        "wos_id": [
                            "WOS:000232916600009"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/j.neuro.2004.12.011",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000232916600009&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0022646/misc/15871752",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0022646/misc",
                    "rm:id": "15871752",
                    "rm:user_id": "1000062092",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000062092",
                    "rm:creator_type": "myself",
                    "rm:created": "2005-12-07T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-05-07T10:32:13Z",
                    "paper_title": {
                        "en": "Anticonvulsant and neuroprotective effects of the novel nootropic agent nefiracetam on kainic acid-induced seizures in rats"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "Y Kitano"
                            },
                            {
                                "name": "C Komiyama"
                            },
                            {
                                "name": "M Makino"
                            },
                            {
                                "name": "K Takasuna"
                            },
                            {
                                "name": "H Satoh"
                            },
                            {
                                "name": "T Aoki"
                            },
                            {
                                "name": "M Kinoshita"
                            },
                            {
                                "name": "A Takazawa"
                            },
                            {
                                "name": "T Yamauchi"
                            },
                            {
                                "name": "S Sakurada"
                            }
                        ]
                    },
                    "description": {
                        "en": "Nefiracetam is a novel pyrrolidone-type nootropic agent, and it has been reported to possess a potential for antiepileptic therapy as well as cognition-enhancing effects. We investigated the anticonvulsant and neuroprotective effects of nefiracetam in kainic acid-induced seizures of rats, compared with levetiracetam and standard antiepileptic drugs. Subcutaneous injection of kainic acid (10 mg/kg) induced typical behavioral seizures such as wet dog shakes and limbic seizures and histopathological changes in the hippocampus (degeneration and loss of pyramidal cells in CA1 to CA4 areas). Nefiracetam (25, 50 and 100 mg/kg po) had no effect on the behavioral seizures and dose-dependently inhibited the hippocampal damage. In contrast, levetiracetam, a pyrrolidone-type antiepileptic drug, inhibited neither. Valproic acid and ethosuximide prevented the hippocampal damage without attenuating the behavioral seizures as nefiracetam. Zonisamide and phenytoin did not inhibit the behavioral seizures, while zonisamide enhanced the hippocampal damage and phenytoin increased the lethality rate. Carbamazepine inhibited the behavioral seizures at 50 mg/kg and enhanced that at 100 mg/kg, and it completely inhibited the hippocampal damage at both doses. We have previously reported that anticonvulsant spectrum of nefiracetam paralleled that of zonisamide, phenytoin or carbamazepine in standard screening models. However, the pharmacological profile of nefiracetam was closer to valproic acid or ethosuximide than that of zonisamide, phenytoin or carbamazepine in this study. These results suggest that anticonvulsant spectrum and mechanism of nefiracetam are distinct from those of standard antiepileptic drugs, and nefiracetam possesses a neuroprotective effect that is unrelated to seizure inhibition. (c) 2005 Elsevier B.V. All rights reserved."
                    },
                    "publisher": {
                        "en": "ELSEVIER SCIENCE BV"
                    },
                    "publication_date": "2005-09",
                    "publication_name": {
                        "en": "BRAIN RESEARCH"
                    },
                    "volume": "1057",
                    "number": "1-2",
                    "starting_page": "168",
                    "ending_page": "176",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1016/j.brainres.2005.07.052"
                        ],
                        "issn": [
                            "0006-8993"
                        ],
                        "wos_id": [
                            "WOS:000232550300020"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/j.brainres.2005.07.052",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000232550300020&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0022646/misc/15871522",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0022646/misc",
                    "rm:id": "15871522",
                    "rm:user_id": "1000062092",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000062092",
                    "rm:creator_type": "myself",
                    "rm:created": "2005-12-07T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-05-07T10:32:13Z",
                    "paper_title": {
                        "en": "Anticonvulsant and neuroprotective effects of the novel nootropic agent nefiracetam on kainic acid-induced seizures in rats"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "Y Kitano"
                            },
                            {
                                "name": "C Komiyama"
                            },
                            {
                                "name": "M Makino"
                            },
                            {
                                "name": "K Takasuna"
                            },
                            {
                                "name": "H Satoh"
                            },
                            {
                                "name": "T Aoki"
                            },
                            {
                                "name": "M Kinoshita"
                            },
                            {
                                "name": "A Takazawa"
                            },
                            {
                                "name": "T Yamauchi"
                            },
                            {
                                "name": "S Sakurada"
                            }
                        ]
                    },
                    "description": {
                        "en": "Nefiracetam is a novel pyrrolidone-type nootropic agent, and it has been reported to possess a potential for antiepileptic therapy as well as cognition-enhancing effects. We investigated the anticonvulsant and neuroprotective effects of nefiracetam in kainic acid-induced seizures of rats, compared with levetiracetam and standard antiepileptic drugs. Subcutaneous injection of kainic acid (10 mg/kg) induced typical behavioral seizures such as wet dog shakes and limbic seizures and histopathological changes in the hippocampus (degeneration and loss of pyramidal cells in CA1 to CA4 areas). Nefiracetam (25, 50 and 100 mg/kg po) had no effect on the behavioral seizures and dose-dependently inhibited the hippocampal damage. In contrast, levetiracetam, a pyrrolidone-type antiepileptic drug, inhibited neither. Valproic acid and ethosuximide prevented the hippocampal damage without attenuating the behavioral seizures as nefiracetam. Zonisamide and phenytoin did not inhibit the behavioral seizures, while zonisamide enhanced the hippocampal damage and phenytoin increased the lethality rate. Carbamazepine inhibited the behavioral seizures at 50 mg/kg and enhanced that at 100 mg/kg, and it completely inhibited the hippocampal damage at both doses. We have previously reported that anticonvulsant spectrum of nefiracetam paralleled that of zonisamide, phenytoin or carbamazepine in standard screening models. However, the pharmacological profile of nefiracetam was closer to valproic acid or ethosuximide than that of zonisamide, phenytoin or carbamazepine in this study. These results suggest that anticonvulsant spectrum and mechanism of nefiracetam are distinct from those of standard antiepileptic drugs, and nefiracetam possesses a neuroprotective effect that is unrelated to seizure inhibition. (c) 2005 Elsevier B.V. All rights reserved."
                    },
                    "publisher": {
                        "en": "ELSEVIER SCIENCE BV"
                    },
                    "publication_date": "2005-09",
                    "publication_name": {
                        "en": "BRAIN RESEARCH"
                    },
                    "volume": "1057",
                    "number": "1-2",
                    "starting_page": "168",
                    "ending_page": "176",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1016/j.brainres.2005.07.052"
                        ],
                        "issn": [
                            "0006-8993"
                        ],
                        "wos_id": [
                            "WOS:000232550300020"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/j.brainres.2005.07.052",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000232550300020&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0022646/misc/15871749",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0022646/misc",
                    "rm:id": "15871749",
                    "rm:user_id": "1000062092",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000062092",
                    "rm:creator_type": "myself",
                    "rm:created": "2005-12-07T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-05-08T23:31:39Z",
                    "paper_title": {
                        "en": "Enhanced antinociception by intracerebroventricularly and intrathecally-administered orexin A and B (hypocretin-1 and-2) in mice"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "JI Mobarakeh"
                            },
                            {
                                "name": "K Takahashi"
                            },
                            {
                                "name": "S Sakurada"
                            },
                            {
                                "name": "S Nishino"
                            },
                            {
                                "name": "H Watanabe"
                            },
                            {
                                "name": "M Kato"
                            },
                            {
                                "name": "K Yanai"
                            }
                        ]
                    },
                    "description": {
                        "en": "Orexins are neuropeptides located exclusively in neurons of the lateral hypothalamic area, which send projections to most monoaminergic nuclei, such as noradrenergic locus coeruleus, dopaminergic ventral tegmental areas, and histaminergic tuberomammillary nuclei. The present work was carried out to examine the role of orexins in nociception in mice. C5713L/6 mice were administered with orexin A and B intracerebroventricularly (i.c.v.), intrathecally (i.t.) and subcutaneously (s.c.) to reveal the sites of action of these peptides and to examine the pain thresholds using four kinds of nociceptive tasks. Orexins showed antinociceptive effects in all four types of assays for thermal (hot-plate, tail-flick, paw-withdrawal), mechanical (tail-pressure), chemical (formalin, capsaicin and abdominal stretch) nociceptions and nociceptininduced behavioral responses, when administered i.c.v. or i.t., whereas the s.c. administration was ineffective. The antinociceptive effects of orexin A were more remarkable than those of orexin B. The i.c.v. administration of orexin A was as effective as, or more potent than the i.t. administration. The effects of orexin A were completely blocked by adenosine type I receptor antagonists, 1,3-dipropyl-8-cyclopentylxanthine (DPCPX) and theophylline, but not by naloxone, suggesting a possible involvement of the adenosine-containing neurons and/or the adenosine pathway in these orexin actions. The i.c.v. administration of nociceptin had no significant effects on orexin expression in the brain and spinal cord. The present findings suggest that orexins have an antinociceptive role in at least four different types of pains, probably acting on both the brain and spinal cord. (c) 2005 Elsevier Inc. All rights reserved."
                    },
                    "publisher": {
                        "en": "ELSEVIER SCIENCE INC"
                    },
                    "publication_date": "2005-05",
                    "publication_name": {
                        "en": "PEPTIDES"
                    },
                    "volume": "26",
                    "number": "5",
                    "starting_page": "767",
                    "ending_page": "777",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1016/j.peptides.2005.01.001"
                        ],
                        "issn": [
                            "0196-9781"
                        ],
                        "wos_id": [
                            "WOS:000228594600009"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/j.peptides.2005.01.001",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000228594600009&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0022646/misc/15871519",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0022646/misc",
                    "rm:id": "15871519",
                    "rm:user_id": "1000062092",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000062092",
                    "rm:creator_type": "myself",
                    "rm:created": "2005-12-07T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-05-08T23:31:39Z",
                    "paper_title": {
                        "en": "Enhanced antinociception by intracerebroventricularly and intrathecally-administered orexin A and B (hypocretin-1 and-2) in mice"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "JI Mobarakeh"
                            },
                            {
                                "name": "K Takahashi"
                            },
                            {
                                "name": "S Sakurada"
                            },
                            {
                                "name": "S Nishino"
                            },
                            {
                                "name": "H Watanabe"
                            },
                            {
                                "name": "M Kato"
                            },
                            {
                                "name": "K Yanai"
                            }
                        ]
                    },
                    "description": {
                        "en": "Orexins are neuropeptides located exclusively in neurons of the lateral hypothalamic area, which send projections to most monoaminergic nuclei, such as noradrenergic locus coeruleus, dopaminergic ventral tegmental areas, and histaminergic tuberomammillary nuclei. The present work was carried out to examine the role of orexins in nociception in mice. C5713L/6 mice were administered with orexin A and B intracerebroventricularly (i.c.v.), intrathecally (i.t.) and subcutaneously (s.c.) to reveal the sites of action of these peptides and to examine the pain thresholds using four kinds of nociceptive tasks. Orexins showed antinociceptive effects in all four types of assays for thermal (hot-plate, tail-flick, paw-withdrawal), mechanical (tail-pressure), chemical (formalin, capsaicin and abdominal stretch) nociceptions and nociceptininduced behavioral responses, when administered i.c.v. or i.t., whereas the s.c. administration was ineffective. The antinociceptive effects of orexin A were more remarkable than those of orexin B. The i.c.v. administration of orexin A was as effective as, or more potent than the i.t. administration. The effects of orexin A were completely blocked by adenosine type I receptor antagonists, 1,3-dipropyl-8-cyclopentylxanthine (DPCPX) and theophylline, but not by naloxone, suggesting a possible involvement of the adenosine-containing neurons and/or the adenosine pathway in these orexin actions. The i.c.v. administration of nociceptin had no significant effects on orexin expression in the brain and spinal cord. The present findings suggest that orexins have an antinociceptive role in at least four different types of pains, probably acting on both the brain and spinal cord. (c) 2005 Elsevier Inc. All rights reserved."
                    },
                    "publisher": {
                        "en": "ELSEVIER SCIENCE INC"
                    },
                    "publication_date": "2005-05",
                    "publication_name": {
                        "en": "PEPTIDES"
                    },
                    "volume": "26",
                    "number": "5",
                    "starting_page": "767",
                    "ending_page": "777",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1016/j.peptides.2005.01.001"
                        ],
                        "issn": [
                            "0196-9781"
                        ],
                        "wos_id": [
                            "WOS:000228594600009"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/j.peptides.2005.01.001",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000228594600009&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0022646/misc/15871748",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0022646/misc",
                    "rm:id": "15871748",
                    "rm:user_id": "1000062092",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000062092",
                    "rm:creator_type": "myself",
                    "rm:created": "2005-12-07T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-05-07T18:29:35Z",
                    "paper_title": {
                        "ja": "A Tyr-W-MIF-1 analogue containing D-Pro2 acts as a selective μ2-opioid receptor antagonist in the mouse",
                        "en": "A Tyr-W-MIF-1 analog containing D-Pro(2) acts as a selective mu(2)-opioid receptor antagonist in the mouse"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "H Watanabe"
                            },
                            {
                                "name": "D Nakayama"
                            },
                            {
                                "name": "K Ito"
                            },
                            {
                                "name": "C Watanabe"
                            },
                            {
                                "name": "H Mizoguchi"
                            },
                            {
                                "name": "T Fujimura"
                            },
                            {
                                "name": "K Murayama"
                            },
                            {
                                "name": "S Kawamura"
                            },
                            {
                                "name": "T Sato"
                            },
                            {
                                "name": "C Sakurada"
                            },
                            {
                                "name": "T Sakurada"
                            },
                            {
                                "name": "S Sakurada"
                            }
                        ]
                    },
                    "description": {
                        "en": "The antagonistic properties of Tyr-D-Pro-Trp-Gly-NH2 (D-Pro(2)-Tyr-W-MIF-1), a Tyr-Pro-Trp-Gly-NH2 (Tyr-W-MIF-1) analog, on the antinociception induced by the mu-opioid receptor agonists Tyr-W-MIF-1, [D-Ala(2),N- Me-Phe(4),Gly(5)-ol]-enkephalin (DAMGO), Tyr-Pro-Trp-Phe-NH2 (endomorphin-1), and Tyr-Pro-Phe-Phe-NH2 (endomorphin-2) were studied in the mouse paw-withdrawal test. D-Pro(2)-Tyr-W-MIF-1 injected intrathecally (i.t.) had no apparent effect on the thermal nociceptive threshold. D-Pro(2)-Tyr-W-MIF-1 (0.1-0.4 nmol) coadministered i.t. showed a dose-dependent attenuation of the antinociception induced by Tyr-W-MIF-1 without affecting endomorphin- or DAMGO-induced antinociception. However, higher doses of D-Pro(2)-Tyr-W-MIF-1 (0.8-1.2 nmol) significantly attenuated endomorphin-1- or DAMGO-induced antinociception, whereas the antinociception induced by endomorphin-2 was still not affected by D-Pro(2)-Tyr-W-MIF-1. Pretreatment i.t. with various doses of naloxonazine, a mu(1)-opioid receptor antagonist, attenuated the antinociception induced by Tyr-W-MIF-1, endomorphin-1, endomorphin-2, or DAMGO. Judging from the ID 50 values for naloxonazine against the antinociception induced by the mu-opioid receptor agonists, the antinociceptive effect of Tyr-W-MIF-1 is extremely less sensitive to naloxonazine than those of endomorphin-1 or DAMGO. In contrast, endomorphin-2-induced antinociception is extremely sensitive to naloxonazine. The present results clearly suggest that D-Pro(2)-Tyr-W-MIF-1 is the selective antagonist to be identified for the mu(2)-opioid receptor in the mouse spinal cord. D-Pro(2)-Tyr-W-MIF-1 may also discriminate between Tyr-W-MIF1-induced antinociception and the antinociception induced by endomorphin-1 or DAMGO, all of which show a preference for the mu(2)-opioid receptor in the spinal cord."
                    },
                    "publisher": {
                        "en": "AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS"
                    },
                    "publication_date": "2005-03",
                    "publication_name": {
                        "ja": "J. Pharmacol. Exp. Ther",
                        "en": "JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS"
                    },
                    "volume": "312",
                    "number": "3",
                    "starting_page": "1075",
                    "ending_page": "1081",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1124/jpet.104.075697"
                        ],
                        "issn": [
                            "0022-3565"
                        ],
                        "wos_id": [
                            "WOS:000227008800023"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1124/jpet.104.075697",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000227008800023&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0022646/misc/15871518",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0022646/misc",
                    "rm:id": "15871518",
                    "rm:user_id": "1000062092",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000062092",
                    "rm:creator_type": "myself",
                    "rm:created": "2005-12-07T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-05-07T18:29:35Z",
                    "paper_title": {
                        "en": "A Tyr-W-MIF-1 analog containing D-Pro(2) acts as a selective mu(2)-opioid receptor antagonist in the mouse"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "H Watanabe"
                            },
                            {
                                "name": "D Nakayama"
                            },
                            {
                                "name": "K Ito"
                            },
                            {
                                "name": "C Watanabe"
                            },
                            {
                                "name": "H Mizoguchi"
                            },
                            {
                                "name": "T Fujimura"
                            },
                            {
                                "name": "K Murayama"
                            },
                            {
                                "name": "S Kawamura"
                            },
                            {
                                "name": "T Sato"
                            },
                            {
                                "name": "C Sakurada"
                            },
                            {
                                "name": "T Sakurada"
                            },
                            {
                                "name": "S Sakurada"
                            }
                        ]
                    },
                    "description": {
                        "en": "The antagonistic properties of Tyr-D-Pro-Trp-Gly-NH2 (D-Pro(2)-Tyr-W-MIF-1), a Tyr-Pro-Trp-Gly-NH2 (Tyr-W-MIF-1) analog, on the antinociception induced by the mu-opioid receptor agonists Tyr-W-MIF-1, [D-Ala(2),N- Me-Phe(4),Gly(5)-ol]-enkephalin (DAMGO), Tyr-Pro-Trp-Phe-NH2 (endomorphin-1), and Tyr-Pro-Phe-Phe-NH2 (endomorphin-2) were studied in the mouse paw-withdrawal test. D-Pro(2)-Tyr-W-MIF-1 injected intrathecally (i.t.) had no apparent effect on the thermal nociceptive threshold. D-Pro(2)-Tyr-W-MIF-1 (0.1-0.4 nmol) coadministered i.t. showed a dose-dependent attenuation of the antinociception induced by Tyr-W-MIF-1 without affecting endomorphin- or DAMGO-induced antinociception. However, higher doses of D-Pro(2)-Tyr-W-MIF-1 (0.8-1.2 nmol) significantly attenuated endomorphin-1- or DAMGO-induced antinociception, whereas the antinociception induced by endomorphin-2 was still not affected by D-Pro(2)-Tyr-W-MIF-1. Pretreatment i.t. with various doses of naloxonazine, a mu(1)-opioid receptor antagonist, attenuated the antinociception induced by Tyr-W-MIF-1, endomorphin-1, endomorphin-2, or DAMGO. Judging from the ID 50 values for naloxonazine against the antinociception induced by the mu-opioid receptor agonists, the antinociceptive effect of Tyr-W-MIF-1 is extremely less sensitive to naloxonazine than those of endomorphin-1 or DAMGO. In contrast, endomorphin-2-induced antinociception is extremely sensitive to naloxonazine. The present results clearly suggest that D-Pro(2)-Tyr-W-MIF-1 is the selective antagonist to be identified for the mu(2)-opioid receptor in the mouse spinal cord. D-Pro(2)-Tyr-W-MIF-1 may also discriminate between Tyr-W-MIF1-induced antinociception and the antinociception induced by endomorphin-1 or DAMGO, all of which show a preference for the mu(2)-opioid receptor in the spinal cord."
                    },
                    "publisher": {
                        "en": "AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS"
                    },
                    "publication_date": "2005-03",
                    "publication_name": {
                        "en": "JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS"
                    },
                    "volume": "312",
                    "number": "3",
                    "starting_page": "1075",
                    "ending_page": "1081",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1124/jpet.104.075697"
                        ],
                        "issn": [
                            "0022-3565"
                        ],
                        "wos_id": [
                            "WOS:000227008800023"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1124/jpet.104.075697",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000227008800023&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0022646/misc/15871747",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0022646/misc",
                    "rm:id": "15871747",
                    "rm:user_id": "1000062092",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000062092",
                    "rm:creator_type": "myself",
                    "rm:created": "2005-12-07T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-05-07T07:31:22Z",
                    "paper_title": {
                        "en": "Pronociceptive role of dynorphins in uninjured animals: N-ethylmaleimide-induced nociceptive behavior mediated through inhibition of dynorphin degradation"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "K Tan-No"
                            },
                            {
                                "name": "H Takahashi"
                            },
                            {
                                "name": "O Nakagawasai"
                            },
                            {
                                "name": "F Niijima"
                            },
                            {
                                "name": "T Sato"
                            },
                            {
                                "name": "S Satoh"
                            },
                            {
                                "name": "S Sakurada"
                            },
                            {
                                "name": "Z Marinova"
                            },
                            {
                                "name": "T Yakovleva"
                            },
                            {
                                "name": "G Bakalkin"
                            },
                            {
                                "name": "L Terenius"
                            },
                            {
                                "name": "T Tadano"
                            }
                        ]
                    },
                    "description": {
                        "en": "Intrathecal (i.t.) administration into mice of N-ethylmaleimide (NEM), a cysteine protease inhibitor, produced a characteristic behavioral response. the biting and/or licking of the hindpaw and the tail along with slight hindlimb scratching directed toward the flank. The behavior induced by NEM was inhibited by the intraperitoneal injection of morphine. We have recently reported that dynorphin A and, more potently big dynorphin, consisting of dynorphins A and B, produce the same type of nociceptive response whereas dynorphin B does not [Tan-No K, Esashi A. Nakagawasai O. Niijima F, Tadano T, Sakurada C, Sakurada T, Bakalkin G, Terenius L, Kisara K. Intrathecally administered big dynorphin, a prodynorphin-derived peptide, produces nociceptive behavior through an N-methyl-D-aspartate receptor mechanism. Brain Res 2002-952:7-14]. The NEM-induced nociceptive behavior was inhibited by pretreatment with dynorphin A- or dynorphin B-antiserum and each antiserum also reduced the nociceptive effects of i.t.-injected synthetic big dynorphin. The characteristic NEM-evoked response was not observed in prodynorphin knockout mice. Naloxone, an opioid receptor antagonist, had no effects on the NEM-induced behavior. Ifenprodil, arcaine and agmatine, antagonists at the polyamine recognition site on the N-methyl-D-aspartate (NMDA) receptor ion-channel complex, and MK-801. an NMDA ion-channel blocker inhibited the NEM-induced effects. Ro25-6981, an antagonist of the NMDA receptor subtype containing NR2B subunit was not active. NEM completely inhibited degradation of dynorphin A by soluble and particulate fractions of mouse spinal cord. Collectively, the results demonstrate that endogenous prodynorphin-derived peptides are pronociceptive in uninjured animals, and required for the NEM-induced behavior. The NEM effects may be mediated through inhibition of the degradation of endogenous dynorphins, presumably big dynorphin that in turn activates the NMDA receptor ion-channel complex by acting on the polyamine recognition site. (C) 2004 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved."
                    },
                    "publisher": {
                        "en": "ELSEVIER SCIENCE BV"
                    },
                    "publication_date": "2005-02",
                    "publication_name": {
                        "en": "PAIN"
                    },
                    "volume": "113",
                    "number": "3",
                    "starting_page": "301",
                    "ending_page": "309",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1016/j.pain.2004.11.004"
                        ],
                        "issn": [
                            "0304-3959"
                        ],
                        "wos_id": [
                            "WOS:000226930300009"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/j.pain.2004.11.004",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000226930300009&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0022646/misc/15871517",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0022646/misc",
                    "rm:id": "15871517",
                    "rm:user_id": "1000062092",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000062092",
                    "rm:creator_type": "myself",
                    "rm:created": "2005-12-07T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-05-07T07:31:22Z",
                    "paper_title": {
                        "en": "Pronociceptive role of dynorphins in uninjured animals: N-ethylmaleimide-induced nociceptive behavior mediated through inhibition of dynorphin degradation"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "K Tan-No"
                            },
                            {
                                "name": "H Takahashi"
                            },
                            {
                                "name": "O Nakagawasai"
                            },
                            {
                                "name": "F Niijima"
                            },
                            {
                                "name": "T Sato"
                            },
                            {
                                "name": "S Satoh"
                            },
                            {
                                "name": "S Sakurada"
                            },
                            {
                                "name": "Z Marinova"
                            },
                            {
                                "name": "T Yakovleva"
                            },
                            {
                                "name": "G Bakalkin"
                            },
                            {
                                "name": "L Terenius"
                            },
                            {
                                "name": "T Tadano"
                            }
                        ]
                    },
                    "description": {
                        "en": "Intrathecal (i.t.) administration into mice of N-ethylmaleimide (NEM), a cysteine protease inhibitor, produced a characteristic behavioral response. the biting and/or licking of the hindpaw and the tail along with slight hindlimb scratching directed toward the flank. The behavior induced by NEM was inhibited by the intraperitoneal injection of morphine. We have recently reported that dynorphin A and, more potently big dynorphin, consisting of dynorphins A and B, produce the same type of nociceptive response whereas dynorphin B does not [Tan-No K, Esashi A. Nakagawasai O. Niijima F, Tadano T, Sakurada C, Sakurada T, Bakalkin G, Terenius L, Kisara K. Intrathecally administered big dynorphin, a prodynorphin-derived peptide, produces nociceptive behavior through an N-methyl-D-aspartate receptor mechanism. Brain Res 2002-952:7-14]. The NEM-induced nociceptive behavior was inhibited by pretreatment with dynorphin A- or dynorphin B-antiserum and each antiserum also reduced the nociceptive effects of i.t.-injected synthetic big dynorphin. The characteristic NEM-evoked response was not observed in prodynorphin knockout mice. Naloxone, an opioid receptor antagonist, had no effects on the NEM-induced behavior. Ifenprodil, arcaine and agmatine, antagonists at the polyamine recognition site on the N-methyl-D-aspartate (NMDA) receptor ion-channel complex, and MK-801. an NMDA ion-channel blocker inhibited the NEM-induced effects. Ro25-6981, an antagonist of the NMDA receptor subtype containing NR2B subunit was not active. NEM completely inhibited degradation of dynorphin A by soluble and particulate fractions of mouse spinal cord. Collectively, the results demonstrate that endogenous prodynorphin-derived peptides are pronociceptive in uninjured animals, and required for the NEM-induced behavior. The NEM effects may be mediated through inhibition of the degradation of endogenous dynorphins, presumably big dynorphin that in turn activates the NMDA receptor ion-channel complex by acting on the polyamine recognition site. (C) 2004 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved."
                    },
                    "publisher": {
                        "en": "ELSEVIER SCIENCE BV"
                    },
                    "publication_date": "2005-02",
                    "publication_name": {
                        "en": "PAIN"
                    },
                    "volume": "113",
                    "number": "3",
                    "starting_page": "301",
                    "ending_page": "309",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1016/j.pain.2004.11.004"
                        ],
                        "issn": [
                            "0304-3959"
                        ],
                        "wos_id": [
                            "WOS:000226930300009"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/j.pain.2004.11.004",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000226930300009&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0022646/misc/15871758",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0022646/misc",
                    "rm:id": "15871758",
                    "rm:user_id": "1000062092",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000062092",
                    "rm:creator_type": "myself",
                    "rm:created": "2005-12-07T15:00:00Z",
                    "rm:modifier_id": "B000000004",
                    "rm:modifier_type": "system",
                    "rm:modified": "2005-12-07T15:00:00Z",
                    "paper_title": {
                        "ja": "Long-lasting effects of yohimbine on the ejaculatory function in male dogs"
                    },
                    "publication_date": "2005",
                    "publication_name": {
                        "ja": "Biomed. Res."
                    },
                    "volume": "26: 201-206",
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.2220/biomedres.26.201"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.2220/biomedres.26.201",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0022646/misc/15871755",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0022646/misc",
                    "rm:id": "15871755",
                    "rm:user_id": "1000062092",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000062092",
                    "rm:creator_type": "myself",
                    "rm:created": "2005-12-07T15:00:00Z",
                    "rm:modifier_id": "B000000004",
                    "rm:modifier_type": "system",
                    "rm:modified": "2005-12-07T15:00:00Z",
                    "paper_title": {
                        "ja": "Intrathecally-administered histamine facilitates nociception through tachykinin NK1 and histamine H1 receptors: A study in histidine decarboxylase gene knockout mice"
                    },
                    "publication_date": "2005",
                    "publication_name": {
                        "ja": "Eur. J. Pharmacol."
                    },
                    "volume": "522: 55-62",
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1016/j.ejphar.2005.08.037"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/j.ejphar.2005.08.037",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0022646/misc/15871754",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0022646/misc",
                    "rm:id": "15871754",
                    "rm:user_id": "1000062092",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000062092",
                    "rm:creator_type": "myself",
                    "rm:created": "2005-12-07T15:00:00Z",
                    "rm:modifier_id": "B000000004",
                    "rm:modifier_type": "system",
                    "rm:modified": "2005-12-07T15:00:00Z",
                    "paper_title": {
                        "ja": "Pharmacological study on the novel antinociceptive agent, a novel monoterpene alkaloid from incarvillea sinensis"
                    },
                    "publication_date": "2005",
                    "publication_name": {
                        "ja": "Biol. Pharm. Bull."
                    },
                    "volume": "28: 1989-1991",
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1248/bpb.28.1989"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1248/bpb.28.1989",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0022646/misc/15871753",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0022646/misc",
                    "rm:id": "15871753",
                    "rm:user_id": "1000062092",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000062092",
                    "rm:creator_type": "myself",
                    "rm:created": "2005-12-07T15:00:00Z",
                    "rm:modifier_id": "B000000004",
                    "rm:modifier_type": "system",
                    "rm:modified": "2005-12-07T15:00:00Z",
                    "paper_title": {
                        "ja": "Effects of nefiracetam, a novel pyrrolidone-type nootropic agent, on the amygdala-kindled seizures in rats"
                    },
                    "publication_date": "2005",
                    "publication_name": {
                        "ja": "Epilepsia"
                    },
                    "volume": "46: 1561-1568",
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1111/j.1528-1167.2005.00261.x"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1111/j.1528-1167.2005.00261.x",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0022646/misc/15871751",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0022646/misc",
                    "rm:id": "15871751",
                    "rm:user_id": "1000062092",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000062092",
                    "rm:creator_type": "myself",
                    "rm:created": "2005-12-07T15:00:00Z",
                    "rm:modifier_id": "B000000004",
                    "rm:modifier_type": "system",
                    "rm:modified": "2005-12-07T15:00:00Z",
                    "paper_title": {
                        "ja": "Anti-inflammatory activities of alpha-truxillic acid derivatives and their monomer components"
                    },
                    "publication_date": "2005",
                    "publication_name": {
                        "ja": "Biol. Pharm. Bull"
                    },
                    "volume": "28: 1776-1778",
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1248/bpb.28.1776"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1248/bpb.28.1776",
                            "is_downloadable": false
                        }
                    ]
                }
            ]
        },
        {
            "@id": "https://api.researchmap.jp/read0022646/association_memberships",
            "@type": "association_memberships",
            "@reverse": "https://api.researchmap.jp/read0022646",
            "total_items": 7,
            "items": [
                {
                    "@id": "https://api.researchmap.jp/read0022646/association_memberships/1862848",
                    "@type": "association_memberships",
                    "@reverse": "https://api.researchmap.jp/read0022646/association_memberships",
                    "rm:id": "1862848",
                    "rm:user_id": "1000062092",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000062092",
                    "rm:creator_type": "myself",
                    "rm:created": "2005-12-07T15:00:00Z",
                    "rm:modifier_id": "1000062092",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2005-12-07T15:00:00Z",
                    "academic_society_name": {
                        "ja": "鎮痛薬オピオイドペプチドシンポジウム"
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/read0022646/association_memberships/1862847",
                    "@type": "association_memberships",
                    "@reverse": "https://api.researchmap.jp/read0022646/association_memberships",
                    "rm:id": "1862847",
                    "rm:user_id": "1000062092",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000062092",
                    "rm:creator_type": "myself",
                    "rm:created": "2005-12-07T15:00:00Z",
                    "rm:modifier_id": "1000062092",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2005-12-07T15:00:00Z",
                    "academic_society_name": {
                        "ja": "日本神経精神薬理学会"
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/read0022646/association_memberships/1862846",
                    "@type": "association_memberships",
                    "@reverse": "https://api.researchmap.jp/read0022646/association_memberships",
                    "rm:id": "1862846",
                    "rm:user_id": "1000062092",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000062092",
                    "rm:creator_type": "myself",
                    "rm:created": "2005-12-07T15:00:00Z",
                    "rm:modifier_id": "1000062092",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2005-12-07T15:00:00Z",
                    "academic_society_name": {
                        "ja": "The Journal of The international association for the study of pain"
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/read0022646/association_memberships/1862845",
                    "@type": "association_memberships",
                    "@reverse": "https://api.researchmap.jp/read0022646/association_memberships",
                    "rm:id": "1862845",
                    "rm:user_id": "1000062092",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000062092",
                    "rm:creator_type": "myself",
                    "rm:created": "2005-12-07T15:00:00Z",
                    "rm:modifier_id": "1000062092",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2005-12-07T15:00:00Z",
                    "academic_society_name": {
                        "ja": "日本疼痛学会"
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/read0022646/association_memberships/1862844",
                    "@type": "association_memberships",
                    "@reverse": "https://api.researchmap.jp/read0022646/association_memberships",
                    "rm:id": "1862844",
                    "rm:user_id": "1000062092",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000062092",
                    "rm:creator_type": "myself",
                    "rm:created": "2005-12-07T15:00:00Z",
                    "rm:modifier_id": "1000062092",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2005-12-07T15:00:00Z",
                    "academic_society_name": {
                        "ja": "日本生理学会"
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/read0022646/association_memberships/1862843",
                    "@type": "association_memberships",
                    "@reverse": "https://api.researchmap.jp/read0022646/association_memberships",
                    "rm:id": "1862843",
                    "rm:user_id": "1000062092",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000062092",
                    "rm:creator_type": "myself",
                    "rm:created": "2005-12-07T15:00:00Z",
                    "rm:modifier_id": "1000062092",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2005-12-07T15:00:00Z",
                    "academic_society_name": {
                        "ja": "日本薬学会"
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/read0022646/association_memberships/1862842",
                    "@type": "association_memberships",
                    "@reverse": "https://api.researchmap.jp/read0022646/association_memberships",
                    "rm:id": "1862842",
                    "rm:user_id": "1000062092",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000062092",
                    "rm:creator_type": "myself",
                    "rm:created": "2005-12-07T15:00:00Z",
                    "rm:modifier_id": "1000062092",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2005-12-07T15:00:00Z",
                    "academic_society_name": {
                        "ja": "日本薬理学会"
                    }
                }
            ]
        },
        {
            "@id": "https://api.researchmap.jp/read0022646/research_projects",
            "@type": "research_projects",
            "@reverse": "https://api.researchmap.jp/read0022646",
            "total_items": 5,
            "items": [
                {
                    "@id": "https://api.researchmap.jp/read0022646/research_projects/2681324",
                    "@type": "research_projects",
                    "@reverse": "https://api.researchmap.jp/read0022646/research_projects",
                    "rm:id": "2681324",
                    "rm:user_id": "1000062092",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000062092",
                    "rm:creator_type": "myself",
                    "rm:created": "2005-12-07T15:00:00Z",
                    "rm:modifier_id": "1000062092",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2005-12-07T15:00:00Z",
                    "research_project_title": {
                        "ja": "CHO cellにおけるMOR-l splice valiants の選択性"
                    },
                    "overall_grant_amount": {
                        "indirect_cost": "0",
                        "total_cost": "0",
                        "direct_cost": "0"
                    },
                    "fund_type": "competitive_research_funding"
                },
                {
                    "@id": "https://api.researchmap.jp/read0022646/research_projects/2681323",
                    "@type": "research_projects",
                    "@reverse": "https://api.researchmap.jp/read0022646/research_projects",
                    "rm:id": "2681323",
                    "rm:user_id": "1000062092",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000062092",
                    "rm:creator_type": "myself",
                    "rm:created": "2005-12-07T15:00:00Z",
                    "rm:modifier_id": "1000062092",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2005-12-07T15:00:00Z",
                    "research_project_title": {
                        "ja": "ストレスとオピオイド"
                    },
                    "overall_grant_amount": {
                        "indirect_cost": "0",
                        "total_cost": "0",
                        "direct_cost": "0"
                    },
                    "fund_type": "competitive_research_funding"
                },
                {
                    "@id": "https://api.researchmap.jp/read0022646/research_projects/2681322",
                    "@type": "research_projects",
                    "@reverse": "https://api.researchmap.jp/read0022646/research_projects",
                    "rm:id": "2681322",
                    "rm:user_id": "1000062092",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000062092",
                    "rm:creator_type": "myself",
                    "rm:created": "2005-12-07T15:00:00Z",
                    "rm:modifier_id": "1000062092",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2005-12-07T15:00:00Z",
                    "research_project_title": {
                        "ja": "疼痛とオピオイド"
                    },
                    "overall_grant_amount": {
                        "indirect_cost": "0",
                        "total_cost": "0",
                        "direct_cost": "0"
                    },
                    "fund_type": "competitive_research_funding"
                },
                {
                    "@id": "https://api.researchmap.jp/read0022646/research_projects/2681321",
                    "@type": "research_projects",
                    "@reverse": "https://api.researchmap.jp/read0022646/research_projects",
                    "rm:id": "2681321",
                    "rm:user_id": "1000062092",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000062092",
                    "rm:creator_type": "myself",
                    "rm:created": "2005-12-07T15:00:00Z",
                    "rm:modifier_id": "1000062092",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2005-12-07T15:00:00Z",
                    "research_project_title": {
                        "en": "Selectivity of MOR-l splice valiants in transfected CHO cell membrances"
                    },
                    "overall_grant_amount": {
                        "indirect_cost": "0",
                        "total_cost": "0",
                        "direct_cost": "0"
                    },
                    "fund_type": "competitive_research_funding"
                },
                {
                    "@id": "https://api.researchmap.jp/read0022646/research_projects/2681320",
                    "@type": "research_projects",
                    "@reverse": "https://api.researchmap.jp/read0022646/research_projects",
                    "rm:id": "2681320",
                    "rm:user_id": "1000062092",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000062092",
                    "rm:creator_type": "myself",
                    "rm:created": "2005-12-07T15:00:00Z",
                    "rm:modifier_id": "1000062092",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2005-12-07T15:00:00Z",
                    "research_project_title": {
                        "en": "Pain and Opioid"
                    },
                    "overall_grant_amount": {
                        "indirect_cost": "0",
                        "total_cost": "0",
                        "direct_cost": "0"
                    },
                    "fund_type": "competitive_research_funding"
                }
            ]
        }
    ]
}